False000115928100011592812022-02-232022-02-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): February 23, 2022
 
ALERISLIFE INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Maryland
(State or Other Jurisdiction of Incorporation)
 
   
1-1681704-3516029
(Commission File Number) (IRS Employer Identification No.)
400 Centre Street, Newton, Massachusetts
 02458
(Address of Principal Executive Offices) (Zip Code)
 
617-796-8387
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common StockALRThe Nasdaq Stock Market LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.  Results of Operations and Financial Condition.
 
On February 23, 2022, AlerisLife Inc., or the Company, issued a press release regarding the Company’s results of operations and financial condition for the quarter ended December 31, 2021. A copy of the Company’s press release is furnished as Exhibit


99.1 hereto. Supplemental information related to the fourth quarter 2021 results is included in the February 2022 investor presentation and is furnished herewith as Exhibit 99.2.
 
Item 9.01.  Financial Statements and Exhibits.
(d)     Exhibits.
 
The Company hereby furnishes the following exhibit:

104Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 ALERISLIFE INC.
 
 By:/s/ Jeffrey C. Leer
  Jeffrey C. Leer
  Executive Vice President, Chief Financial Officer and Treasurer
 
Dated:  February 23, 2022


Grafico Azioni AlerisLife (NASDAQ:ALR)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di AlerisLife
Grafico Azioni AlerisLife (NASDAQ:ALR)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di AlerisLife